BA · Healthcare

Instituto Rosenbusch S.A. (ROSE)

Drug Manufacturers - Specialty & Generic

Instituto Rosenbusch S.A. (ROSE) is listed on BA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ROSE

P/E ratio

18.00

Instituto Rosenbusch S.A. (ROSE) — FAQ

What is ROSE's P/E ratio?

The price-to-earnings (P/E) ratio for Instituto Rosenbusch S.A. (ROSE) is 18.00 (data as of 2026-05-24).

Does Instituto Rosenbusch S.A. pay a dividend?

Dividend yield is not available in the current snapshot for Instituto Rosenbusch S.A. (ROSE). Check the MyAverix Finance app for the latest dividend data.

What sector is Instituto Rosenbusch S.A. in?

Instituto Rosenbusch S.A. (ROSE) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ROSE listed on?

ROSE is listed on BA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)